Cyclosporin A does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat
Open Access
- 1 October 1994
- journal article
- Published by Springer Nature in Calcified Tissue International
- Vol. 55 (4) , 295-301
- https://doi.org/10.1007/bf00310409
Abstract
The weanling rat, an animal model of rapid bone turnover, was used to evaluate the effects of various doses of cyclosporin A (CsA) on various bones during different time periods. Sprague-Dawley male rats were extensively prelabeled with 3H-tetracycline during 1–3 weeks of age. At 4 weeks of age, four groups of rats were given daily subcutaneous injections: vehicle or CsA—low dose (10 mg/kg), intermediary dose (20 mg/kg), or high dose (30 mg/kg) for 7, 14, or 28 days. Three different whole bones—the femur (low turnover), scapula (moderate turnover), and lumbar-6 vertebra (high turnover) were harvested intact at 4, 5, 6, and 8 weeks of age. The whole bones were assayed weekly for total dry defatted weight, calcium mass (formation), and loss of 3H-tetracycline (bone resorption) following treatment with CsA. Serum CsA levels, calcium creatinine, and alkaline phosphatase were measured weekly. Significant decreases in serum calcium and alkaline phosphatase were observed at 1 and 2 weeks, and were normalized by 4 weeks of treatment. No significant changes in serum creatinine were noted. For all three doses of CsA, no effect was observed on the absolute rate of cortical bone resorption of three different, whole bones over three time periods. Body weight and bone formation in treated animals was significantly smaller in a dose- and time-related fashion compared with control animals at sacrifice. However, compared with the initial control animals, body weights and bone masses of the final treated animals were much larger, suggesting that the smaller bone masses were due to insufficient growth and slow gain in bone mass. Our isotopic data demonstrate that CsA has no effect on the basal rate of bone resorption and decreases rate of bone formation, as observed globally at the whole bone level. Bone measurements at the organ level may lead to different interpretations from those observed at the tissue level.Keywords
This publication has 37 references indexed in Scilit:
- Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivoJournal of Bone and Mineral Research, 1994
- FK506 and rapamycin: novel pharmacological probes of the immune responseTrends in Pharmacological Sciences, 1991
- Growth inhibition by cyclosporine a andLife Sciences, 1991
- A Pharmacokinetic Model in the Rat and Rabbit of the Direct Measurement of Mature Bone Resorption In Vivo with [3H] TetracyclineJournal of Pharmaceutical Sciences, 1989
- Different inhibitory actions of immunomodulating agents and immunosuppressive agents on bone resorption of mouse calvariaInternational Journal of Immunopharmacology, 1989
- Action of cyclosporine on mitochondrial calcium fluxesJournal of Bioenergetics and Biomembranes, 1987
- Cyclosporine a inhibits calcemic hormone-induced bone resorption in vitroJournal of Bone and Mineral Research, 1986
- Effect of age on bone resorption at the skeletal level in normal humansBone, 1985
- Bone Absorption and the Immune SystemScandinavian Journal of Immunology, 1981
- Steady-State Relationship of Calcium-45 Between Bone and Blood: Differences in Growing Dogs, Chicks, and RatsScience, 1981